以順鉑載子治療惡性肋膜積液---體外及腫瘤動物模式

Pharmacology, Toxicology and Pharmaceutical Science

1. Cisplatin 100%
2. Malignant Pleura Effusion 100%
3. Cancer Model 100%
4. Chemotherapy 71%
5. Mouse Model 28%
6. Antiinfective Agent 28%
7. Sustained Release 14%
8. Etoposide 14%
9. Drug Absorption 14%
10. Drug Concentration 14%
11. Therapeutic Effect 14%
12. Paclitaxel 14%
13. Sclerosing Agent 14%
14. Pleura Tumor 14%
15. Cytotoxic Agent 14%
16. Drug Delivery System 14%
17. Survival Time 14%
18. Disease 14%
19. Pemetrexed 14%
20. Neoplasm 14%
21. Dyspnea 14%
22. Infection 14%
23. Mouse 7%

Medicine and Dentistry

1. Cancer Model 100%
2. Malignant Pleural Effusion 100%
3. Cisplatin 100%
4. Intrapleural Drug Administration 42%
5. Antiinfective Agent 28%
6. Chemotherapy 14%
7. Cytotoxic Agent 14%
8. Therapy Effect 14%
9. Disease 14%
10. Pleural Cavity 14%
11. Survival Time 14%
12. Drug Absorption 14%
13. Pleura Tumor 14%
14. Drug Delivery System 14%
15. In Vitro 14%
16. Pleurodesis 14%
17. Infection 14%
18. Pemetrexed 14%
19. Neoplasm 14%
20. Sclerosing Agent 14%
21. Dyspnea 14%
22. Sustained Drug Release 14%
23. Cancer 14%
24. Paclitaxel 14%
25. Etoposide 14%